Pharmaceutical Industry news

• Multicancer Early Detection Blood Tests Are Feasible

  06-10-2023 18:00 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- Multicancer early detection (MCED) blood tests are feasible for detecting cancer, according to a study published online Oct. 5 in The Lancet.
  Deb Schrag, M.D., from the Memorial Sloan Kettering Cancer Center in New York City,...
  
  Read more

• GI Adverse Events Increased With Use of GLP-1 Agonists for Weight Loss

  06-10-2023 17:41 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- Use of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss is associated with increased risks for pancreatitis, gastroparesis, and bowel obstruction compared with use of bupropion-naltrexone, according to a...
  
  Read more

• Hybrid Closed-Loop Insulin Improves Glycemic Control in T1D-Complicated Pregnancy

  06-10-2023 17:39 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- For pregnant women with type 1 diabetes, hybrid closed-loop insulin therapy significantly improves maternal glycemic control, according to a study published online Oct. 5 in the New England Journal of Medicine to coincide...
  
  Read more

• Prevalence of Hearing Loss Significantly Higher for Cancer Survivors

  06-10-2023 17:35 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- Cancer survivors have a significantly higher prevalence of hearing loss (HL) than the general population, according to a study published online Oct. 5 in JAMA Otolaryngology-Head and Neck Surgery.
  Qian Wang, M.D., M.P.H.,...
  
  Read more

• Advertisement

• COACH Intervention May Reduce Instances of Elder Mistreatment

  06-10-2023 17:33 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- A remotely delivered caregiver intervention may be effective at preventing elder mistreatment, according to a pilot study published online Oct. 4 in the Journal of the American Geriatrics Society.
  Zachary D. Gassoumis, Ph.D.,...
  
  Read more

• Reductions Seen in HbA1c, Body Weight With Once-Weekly Tirzepatide

  06-10-2023 17:25 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- For patients with inadequately controlled type 2 diabetes, once-weekly subcutaneous injections of tirzepatide yield reductions in hemoglobin A1c (HbA1c) and body weight compared with insulin lispro, according to a study...
  
  Read more

• Diabetes More Prevalent in Black Patients With Multiple Myeloma

  06-10-2023 17:22 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- Diabetes mellitus (DM) is more prevalent among Black patients with multiple myeloma (MM) and is associated with overall survival in MM, especially among White patients, according to a study published online Sept. 29 in Blood...
  
  Read more

• Efgartigimod Efficacious, Safe for Primary Immune Thrombocytopenia

  06-10-2023 17:19 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic or persistent primary immune thrombocytopenia, according to a study published online Sept. 28 in...
  
  Read more

• Advertisement

• Higher CPAP Adherence Tied to Reduction in Cardiovascular Events

  06-10-2023 17:16 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- Adherence to continuous positive airway pressure (CPAP) treatment is associated with a reduced risk for cardiovascular event recurrence, according to a review published in the Oct. 3 issue of the Journal of the American...
  
  Read more

• Loneliness Increases Risk for Incident Parkinson Disease

  06-10-2023 17:13 via drugs.com
  
  FRIDAY, Oct. 6, 2023 -- Loneliness is associated with the risk for incident Parkinson disease (PD), independent of other risk factors, according to a study published online Oct. 2 in JAMA Neurology.
  Antonio Terracciano, Ph.D., from Florida State...
  
  Read more

• Roche presents positive results for spinal muscular atrophy treatment Evrysdi in babies

  06-10-2023 13:31
  
  The progressive neuromuscular disease affects approximately one in every 10,000 babies
  
  Read more

• AbbVie announces acquisition of Mitokinin in deal worth over $650m

  06-10-2023 13:31
  
  The agreement gives AbbVie access to a potential treatment for Parkinson’s disease
  
  Read more

• AbbVie acquires Mitokinin in deal worth over $650m

  06-10-2023 13:31
  
  The agreement gives AbbVie access to a potential treatment for Parkinson’s disease
  
  Read more

• Nanobiotix shares promising results for radiotherapy enhancer in advanced pancreatic cancer

  06-10-2023 13:30
  
  More than 90% of patients with locally advanced disease are not eligible for surgery
  
  Read more

• BioIndustry Association reveals how UK is set to become a global leader in mRNA

  06-10-2023 13:29
  
  Several companies and organisations have supported the development of mRNA
  
  Read more

• NCCN: Cancer Centers Still Experiencing Shortages of Chemo Drugs

  06-10-2023 00:55 via drugs.com
  
  THURSDAY, Oct. 5, 2023 -- Many cancer centers are still experiencing a shortage of carboplatin, cisplatin, and other chemotherapy drugs, according to the results of a follow-up survey conducted Sept. 6 to 20, 2023, by the National Comprehensive...
  
  Read more

• Psychotropic Medication Use Up in Children, Teens With Type 1 Diabetes

  06-10-2023 00:52 via drugs.com
  
  THURSDAY, Oct. 5, 2023 -- Dispensing of psychotropic medication increased among children and adolescents with type 1 diabetes (T1D) from 2006 to 2019, according to a study published online Oct. 3 in JAMA Network Open.
  Shengxin Liu, from the...
  
  Read more

• In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine

  06-10-2023 00:49 via drugs.com
  
  THURSDAY, Oct. 5, 2023 -- Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19.
  In interim findings from a phase 1/2 trial, the vaccine showed a strong...
  
  Read more

• CDC Stops Issuing New COVID-19 Vaccination Cards

  06-10-2023 00:46 via drugs.com
  
  THURSDAY, Oct. 5, 2023 -- Wallet-friendly cards showing proof of COVID-19 vaccinations served a purpose early in the pandemic, but they are on their way out. The U.S. Centers for Disease Control and Prevention has stopped printing the cards, likely...
  
  Read more

• 70 Million 'Slime Licker' Candies Recalled Due to Choking Risk

  06-10-2023 00:43 via drugs.com
  
  THURSDAY, Oct. 5, 2023 -- Candy Dynamics Inc. said Thursday it is recalling 70 million of its candies because they can pose a choking hazard. The recall is for its "Slime Licker Sour Rolling Liquid Candies." Consumers should immediately stop using...
  
  Read more

Follow @PharmaIndustry_ on Twitter!